Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes
Insulet awarded $452M in EOFlow patent fight by Elise Reuter for MedTechDive.com, 5 December 2024. Insulet sued EOFlow and three former executives who joined the South Korea-based patch-pump maker, claiming the company “launched a plan to brazenly copy Insulet’s...
Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care
Embecta discontinues insulin patch pump development by Elise Reuter for MedTechDive.com, 26 November 2024. Embecta said it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The...
Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation
In this week’s issue of The Savvy Diabetic: FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU...
Savvy Updates 11/18/24: NovoNordisk Phasing Out Human Insulin Pens, Sequel/Twiist AID, History of Artificial Pancreas
Novo Nordisk says it is gradually phasing out human insulin pens globally by Maggie Fick for Reuters.com, 14 November 2024. Novo Nordisk is gradually ending production of human insulin pens, as it spends billions to ramp up manufacturing of its popular obesity and...
More Diabetes Blogs